Clustering data with hclust algorithm for Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) (Study ST001517)

Reversed phase UNSPECIFIED ION MODE (Analysis AN002520)
MetaboliteStructureF1F2
3-hydroxybutyrate (BHBA)ME3668320.711.29
threonateME3668120.621.38
2,2^-Methylenebis(6-tert-butyl-p-cresol)ME3668461.240.76
2-hydroxyadipateME3668171.330.73
3-hydroxysebacateME3668290.841.15
mannitol/sorbitolME3667960.841.16
sebacate (C10-DC)ME3668240.841.16
3-sulfo-L-alanineME3667860.851.16
riboseME3668080.851.15
gentisateME3667900.881.11
glutarate (C5-DC)ME3668200.891.11
ethylmalonateME3667840.921.08
glycerateME3668000.911.09
quinateME3668550.911.09
maleateME3668221.050.95
orotidineME3668421.050.95
Fibrinopeptide B (1-9)**ME3668441.040.95
N-acetylserineME3667791.040.96
myo-inositolME3668311.040.96
lactateME3668011.040.96
fumarateME3668141.040.96
2,3-dihydroxyisovalerateME3668491.040.96
erythritolME3668521.040.96
N-acetylalanineME3667761.020.98
mannonate*ME3668541.020.98
dihydroorotateME3668401.020.98
arabitol/xylitolME3668041.020.98
1-methylurateME3668561.020.98
3-methylglutaconateME3667821.020.98
orotateME3668411.030.97
2-hydroxybutyrate/2-hydroxyisobutyrateME3667781.030.97
2-hydroxyphenylacetateME3667881.030.97
xyloseME3668101.010.99
succinateME3668151.010.99
mannoseME3667971.010.99
glycerophosphoglycerolME3668301.010.99
fructoseME3667941.010.99
gluconateME3668531.010.99
alpha-ketobutyrateME3667870.991.00
methylsuccinateME3667851.001.00
glucoseME3667991.001.00
arabinoseME3668031.001.00
3-hydroxyisobutyrateME3667811.001.00
1-linoleoyl-GPA (18:2)*ME3668341.001.00
2S,3R-dihydroxybutyrateME3668261.001.00
perfluorooctanesulfonate (PFOS)ME3668470.951.05
suberate (C8-DC)ME3668250.951.05
3-hydroxyadipate*ME3668180.931.07
ribulonate/xylulonate/lyxonate*ME3668090.941.06
ribitolME3668060.991.01
methylmalonate (MMA)ME3668160.991.01
heptenedioate (C7:1-DC)*ME3668210.991.01
arabonate/xylonateME3668050.991.01
erythronate*ME3667920.991.01
pimelate (C7-DC)ME3668230.991.02
xanthineME3668390.981.02
gulonate*ME3668110.981.02
alpha-ketoglutaramate*ME3667770.981.02
2-isopropylmalateME3668500.981.02
3,4-dihydroxybutyrateME3668270.981.02
glucuronateME3667930.961.04
ribonateME3668070.971.03
3-hydroxy-3-methylglutarateME3668370.971.03
pyruvateME3668020.971.03
allantoinME3668381.150.85
galactonateME3667951.160.84
hydantoin-5-propionateME3667801.160.84
3-methyladipateME3668191.070.91
alpha-hydroxyisovalerateME3667831.080.92
alpha-ketoglutarateME3668131.070.93
1-palmitoyl-GPA (16:0)ME3668361.070.93
2-hydroxyheptanoate*ME3668281.070.93
uracilME3668431.100.89
salicylateME3668481.100.90
maltoseME3667981.100.90
1-arachidonoyl-GPA (20:4)ME3668331.100.90
2-keto-3-deoxy-gluconateME3668511.100.90
1-oleoyl-GPA (18:1)ME3668351.130.87
homocitrullineME3667911.120.89
2-hydroxyhippurate (salicylurate)ME3668451.120.88
phenylpyruvateME3667891.120.88

Factors:

F1Infection:Infected
F2Infection:Non-infected
Data matrix
  logo